The TOPRA Annual Symposium

The TOPRA Annual Symposium is the largest forum for European regulatory professionals to meet up, discuss current regulatory issues and debate future plans for regulation.

This event attracts key professionals from major pharmaceutical companies, small and medium-sized enterprises, regulatory agencies, biotech companies, support companies, consultants, academia, patient groups and legal services.

There are three symposia taking place across the three days: Human MedicinesVeterinary Medicines and Medical Devices. This year’s theme is ‘Collaboration, strategies and solutions: global regulatory approaches to improve healthcare’.

Why do delegates attend?

There are five reasons that make the TOPRA Annual Symposium the most comprehensive regulatory affairs conference in Europe:

  • Knowledge: an exclusive focus on a broad range of emerging regulatory trends and issues with practical solutions
  • Professional development: the opportunity for delegates to learn from a rich faculty of speakers at the forefront of their specialism
  • Contacts: direct access to both delegates and speakers who are the innovators and experts of tomorrow
  • Networking: a diverse European and rest of world audience to learn from and interact with
  • Access to regulators: key topic experts from the EMA and other agencies will be present, providing the inside track on how the key regulatory issues are affected by the current political climate.

What do delegates say?

“The only relevant choice for regulatory affairs in the UK. Relevant and current and generally have a European focus.”

“To be part a community of experts, striving for excellence and sharing knowledge, for the betterment of patients and medicines globally.”

 “A regulatory excellence indicator”

How to view the programme and book tickets

The full programme is now live and tickets are available for each conference on our website at the following links:

Human Medicines - Veterinary Medicines - Medical Devices

An early bird is also in place for the remainder of June on tickets to the Human Medicines and Medical Devices sessions. In addition, TOPRA are also running a member campaign which also offers further discount on all tickets if you become a member.




SpeeDx and Diagen sign new distribution agreement for Scandinavia

SYDNEY, AUSTRALIA – (Sept 19, 2017). SpeeDx Pty, Ltd. has announced a distribution agreement with D...

Read More >

OGT pushes forward hybridisation-based targeted sequencing

Oxford, UK – 25 May 2017. Oxford Gene Technology (OGT), The Molecular Genetics Company, has made se...

Read More >

Strategic Partnership for New Bladder Cancer Diagnostic Test in the UK

Alpha Laboratories Ltd. (Eastleigh, UK) is delighted to have been appointed as the exclusive distrib...

Read More >

EKF launches pocket-sized lactate monitor for sports performance monitoring at MEDICA 2018

Cardiff, UK – 22nd October 2018 – EKF Diagnostics, the global in vitro diagnostics company, announ...

Read More >

EKF Quo-Test® supports improved medical management of diabetic retinopathy patients

POC HbA1c study at Great Western Hospitals NHS Foundation Trust is finalist for 2019 RCOphth/Bausch...

Read More >

SpeeDx and Thermo Fisher Scientific announce strategic partnership for FDA clearance of molecular diagnostic test

SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has signed an agreement ...

Read More >